| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.52B | 23.79B | 26.87B | 21.49B | 20.98B | 20.26B |
| Gross Profit | 25.52B | 22.84B | 26.77B | 21.37B | 20.83B | 20.07B |
| EBITDA | 5.27B | 6.20B | 4.67B | 4.08B | 3.25B | 3.21B |
| Net Income | 4.03B | 4.01B | 3.07B | 2.66B | 2.11B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 1.55T | 1.53T | 1.52T | 1.50T | 1.68T | 1.67T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 111.06B | 134.17B | 90.16B | 279.21B | 316.40B |
| Total Debt | 1.24B | 1.36B | 1.62B | 1.73B | 370.36B | 353.58B |
| Total Liabilities | 1.46T | 1.44T | 1.44T | 1.42T | 1.60T | 1.59T |
| Stockholders Equity | 87.72B | 86.46B | 86.04B | 75.27B | 75.37B | 74.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.71B | 0.00 | -212.06B | -31.48B | 213.03B |
| Operating Cash Flow | 0.00 | 5.29B | 0.00 | -210.95B | -30.53B | 213.67B |
| Investing Cash Flow | 0.00 | -4.99B | 71.83B | 22.79B | -5.78B | -837.00M |
| Financing Cash Flow | 0.00 | -1.90B | 17.86B | -546.00M | -591.00M | -465.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥37.49B | 24.09 | ― | 2.87% | 21.47% | 153.64% | |
72 Outperform | ¥23.67B | 7.08 | ― | 3.50% | 17.01% | 22.39% | |
68 Neutral | ¥38.67B | 10.62 | ― | 3.28% | 18.67% | -17.66% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥17.77B | 4.85 | ― | 3.37% | 3.48% | 64.48% | |
65 Neutral | ¥49.18B | 4.49 | ― | 1.20% | 14.35% | 253.31% | |
64 Neutral | ¥29.11B | 7.87 | ― | 2.59% | 12.72% | ― |